Neural Regeneration Research

Article	Citations
Generating oligodendroglia from adult mesenchymal cells for transplantation: cell reprogramming or direct lineage conversion?	360
Chronic traumatic encephalopathy: genes load the gun and repeated concussion pulls the trigger	302
Contribution of adult-born neurons to memory consolidation during rapid eye movement sleep	206
Functions of nuclear factor Y in nervous system development, function and health	172
Porcine decellularized nerve matrix hydrogel attenuates neuroinflammation after peripheral nerve injury by inhibiting the TLR4/MyD88/NF-κB axis	133
Protocadherin gamma C3: a new player in regulating vascular barrier function	115
The power of “touch” and early enriched stimulation: neuroplasticity effects in rodents and preterm infants	109
FKBP51: A new target for Parkinson’s disease	98
Rbm8a regulates neurogenesis and reduces Alzheimer’s disease-associated pathology in the dentate gyrus of 5×FAD mice	95
Retraction: Emerging concepts underlying selective neuromuscular dysfunction in infantile-onset spinal muscular atrophy	78
Mitochondrial transplantation: a promising strategy for the treatment of retinal degenerative diseases	76
Potential common pathogenesis of several neurodegenerative diseases	73
SCFD1 in amyotrophic lateral sclerosis: reconciling a genetic association with in vivo functional analysis	67
Exercise-with-melatonin therapy improves sleep disorder and motor dysfunction in a rat model of ischemic stroke	67
Increased activation of the caudate nucleus and parahippocampal gyrus in Parkinson’s disease patients with dysphagia after repetitive transcranial magnetic stimulation: a case-control study	65
The delivery of miR-21a-5p by extracellular vesicles induces microglial polarization via the STAT3 pathway following hypoxia-ischemia in neonatal mice	65
GDNF to the rescue: GDNF delivery effects on motor neurons and nerves, and muscle re-innervation after peripheral nerve injuries	63
Bradykinin postconditioning protects rat hippocampal neurons after restoration of spontaneous circulation following cardiac arrest via activation of the AMPK/mTOR signaling pathway	60
The role of miRNA in retinal ganglion cell health and disease	59
Necrostatin-1 decreases necroptosis and inflammatory markers after intraventricular hemorrhage in mice	58
Tropism-shifted AAV-PHP.eB-mediated bFGF gene therapy promotes varied neurorestoration after ischemic stroke in mice	57
The circ_0002538/miR-138-5p/plasmolipin axis regulates Schwann cell migration and myelination in diabetic peripheral neuropathy	57
Role of the globus pallidus in motor and non-motor symptoms of Parkinson’s disease	56
LL-37 and CsgC exemplify the crosstalk between anti-amyloid, antimicrobial, and anti-biofilm protein activities	56
Autolysosomal acidification impairment as a mediator for TNFR1 induced neuronal necroptosis in Alzheimer's disease	56

Phosphorylated tau as a toxic agent in synaptic mitochondria: implications in aging and Alzheimer’s disease	54
Exosomes derived from bone marrow mesenchymal stem cells protect the injured spinal cord by inhibiting pericyte pyroptosis	53
Therapeutic potential of glial cell line-derived neurotrophic factor and cell reprogramming for hippocampal-related neurological disorders	53
Glymphatic imaging and modulation of the optic nerve	52
Could inorganic polyphosphate be a valid target against neuronal senescence?	51
Activity-dependent regulation of cortical cell numbers: Role of neuronal activity in cortical circuit formation	51
Synaptopathy in CHMP2B frontotemporal dementia highlights the synaptic vesicle cycle as a therapeutic target	51
Beyond apoptosis: Implications of annexin-V binding to myeloid cells in DARC (Detection of Apoptosing Retinal Cells) imaging	50
Krüppel-like factor 2 (KLF2), a potential target for neuroregeneration	48
Mechanosensitivity of N-methyl-D-aspartate receptors (NMDAR) is the key through which amyloid beta oligomers activate them	48
Facial reanimation with interposition nerve graft or masseter nerve transfer: a comparative retrospective study	48
Human endogenous retrovirus type-W and multiple sclerosis–related smoldering neuroinflammation	47
The complex roles of m6A modifications in neural stem cell proliferation, differentiation, and self-renewal and implications for memory and neurodegenerative diseases	47
Chx10+V2a interneurons in spinal motor regulation and spinal cord injury	47
Increased retinal venule diameter as a prognostic indicator for recurrent cerebrovascular events: a prospective observational study	47
Enhancement of lysosome biogenesis as a potential therapeutic approach for neurodegenerative diseases	47
Neuroserpin alleviates cerebral ischemia-reperfusion injury by suppressing ischemia-induced endoplasmic reticulum stress	46
NECAB family of neuronal calcium-binding proteins in health and disease	46
Telomere length as a predictive marker for long-term cognitive function in a mouse model of subarachnoid hemorrhage	45
Dual-targeting AAV9P1-mediated neuronal reprogramming in a mouse model of traumatic brain injury	45
Prolonged intermittent theta burst stimulation restores the balance between A2AR- and A1R-mediated adenosine signaling in the 6-hydroxidopamine model of Parkinson’s disease	45
The intrinsic excitability of and autophagy protein expression levels in dentate gyrus ensembles regulate fear generalization	45
Activation of medial septum cholinergic neurons restores cognitive function in temporal lobe epilepsy	45
Phosphorylation-driven aggregative proteins in neurodegenerative diseases: implications and therapeutics	44
Delayed microglial depletion protects against white matter injury following neonatal cerebral hemorrhage in mice	43
Transcription factors promote neural regeneration after spinal cord injury	43
Stepping up after spinal cord injury: negotiating an obstacle during walking	43
Small extracellular vesicles secreted by induced pluripotent stem cell-derived mesenchymal stem cells improve postoperative cognitive dysfunction in mice with diabetes	42
Astrocyte chloride, excitatory-inhibitory balance and epilepsy	42
Peripheral mitochondrial DNA as a neuroinflammatory biomarker for major depressive disorder	42
Rapamycin as a preventive intervention for Alzheimer’s disease in APOE4 carriers: Targeting brain metabolic and vascular restoration	42
Multiple factors to assist human-derived induced pluripotent stem cells to efficiently differentiate into midbrain dopaminergic neurons	42
Ethanol changes Nestin-promoter induced neural stem cells to disturb newborn dendritic spine remodeling in the hippocampus of mice	42
Neuromodulation techniques for modulating cognitive function: Enhancing stimulation precision and intervention effects	42
Rapid GFAP and Iba1 expression changes in the female rat brain following spinal cord injury	42
Downregulation of miR-491-5p promotes neovascularization after traumatic brain injury	41
Mitochondrial dynamics dysfunction and neurodevelopmental disorders: From pathological mechanisms to clinical translation	41
Clemastine in remyelination and protection of neurons and skeletal muscle after spinal cord injury	41
Selective deletion of zinc transporter 3 in amacrine cells promotes retinal ganglion cell survival and optic nerve regeneration after injury	41
Involvement of glucose transporter overexpression in the protection or damage after ischemic stroke	40
Decoding molecular mechanisms: brain aging and Alzheimer’s disease	40
Neuropsychiatric symptoms and apolipoprotein E genotypes in neurocognitive disorders	40
Axonal protein synthesis in central nervous system regeneration: is building an axon a local matter?	39
Neurogenesis dynamics in the olfactory bulb: deciphering circuitry organization, function, and adaptive plasticity	39
Mesenchymal stem cell-derived extracellular vesicles therapy in traumatic central nervous system diseases: a systematic review and meta-analysis	39
Amyloid-beta and tau protein beyond Alzheimer’s disease	39
Metformin promotes angiogenesis and functional recovery in aged mice after spinal cord injury by adenosine monophosphate-activated protein kinase/endothelial nitric oxide synthase pathway	38
Role of copper chelating agents: between old applications and new perspectives in neuroscience	38
Functional near-infrared spectroscopy in non-invasive neuromodulation	38
Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy	38

Eph receptor A4 regulates motor neuron ferroptosis in spinal cord ischemia/reperfusion injury in rats	38
Insights from an academic endeavor into central nervous system drug discovery	37
Liposomes as versatile agents for the management of traumatic and nontraumatic central nervous system disorders: drug stability, targeting efficiency, and safety	37
Utility of droplet digital polymerase chain reaction for studying somatic mosaicism: brain malformations and beyond	37
New aspects of a small GTPase RAB35 in brain development and function	36
Endorepellin downregulation promotes angiogenesis after experimental traumatic brain injury	36
Brain ischemia as a bridge to Alzheimer’s disease	36
Amyotrophic lateral sclerosis disease burden: doing better at getting better	36
Premature axon-oligodendrocyte interaction contributes to stalling of experimental axon regeneration after injury to the white matter	35
Exploration of C-terminal CX3CL1 for reducing age-dependent neurodegeneration	35
Retraction: Ultrasound guided neural stem cell transplantation through the lateral ventricle for treatment of cerebral palsy in children	34
Exploring the novel role of oligodendrocyte precursor cells in phagocytosis: beyond myelinogenesis	34
Newfound physiological function of FAIM protein offers hope of novel disease-modifying therapy for Alzheimer’s disease	34
Modulation of p75 neurotrophin receptor mitigates brain damage following ischemic stroke in mice	34
Cell senescence, loss of splicing, and lipid metabolism in TDP-43-related neurodegenerative processes	34
Advances in non-invasive imaging of proteinopathies in animal models of neurodegenerative diseases	34
Bidirectional communication between the gut microbiota and the central nervous system	33
Unraveling the role of ufmylation in the brain	33
Extracellular vesicles: multiple signaling capabilities and translation into promising therapeutic targets to promote neuronal plasticity	33
Targeting muscle to treat Charcot-Marie-Tooth disease	33
Optical tissue clearing enables rapid, precise and comprehensive assessment of three-dimensional morphology in experimental nerve regeneration research	33
Ki20227 aggravates apoptosis, inflammatory response, and oxidative stress after focal cerebral ischemia injury	33
Neuronal and endothelial transglutaminase-2 expression in experimental autoimmune encephalomyelitis and multiple sclerosis	32
Optogenetics stimulates nerve reorganization in the contralesional anterolateral primary motor cortex in a mouse model of ischemic stroke	32
Designing nanocarriers to overcome the limitations in conventional drug administration for Parkinson’s disease	32
Exercise training promotes nerve cell repair and regeneration after spinal cord injury	32
On the functions of astrocyte-mediated neuronal slow inward currents	32
New insights into the role of the endoplasmic reticulum in microglia	32
Dynamic regulation of the developmental establishment of the adult hippocampal neural stem cell pool	31
Exendin-4 and linagliptin attenuate neuroinflammation in a mouse model of Parkinson′s disease	31
Therapeutic effects of low-intensity transcranial focused ultrasound stimulation on ischemic stroke in rats: An in vivo evaluation using electrical impedance tomography	31
Converging assemblies: A putative building block for brain function and for interfacing with the brain	31
Sex modulates the outcome of subthalamic nucleus deep brain stimulation in patients with Parkinson’s disease	31
Prediction of cell-cell communication patterns of dorsal root ganglion cells: single-cell RNA sequencing data analysis	31
New insights on the role of chondroitin sulfate proteoglycans in neural stem cell–mediated repair in spinal cord injury	31
Argatroban promotes recovery of spinal cord injury by inhibiting the PAR1/JAK2/STAT3 signaling pathway	31
Delta-opioid receptor–mediated neural protection and regeneration	30
Crosstalk among canonical Wnt and Hippo pathway members in skeletal muscle and at the neuromuscular junction	30
Application of artificial intelligence for the prediction of amyloidoses	30
Multimodal MRI combined with RNA sequencing reveals pathological signatures in the 9-month-old 3×Tg-AD mouse brain	30
Commentary on “PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons”	30
Effects of C2 hemisection on respiratory and cardiovascular functions in rats	30
Artificial intelligence and peripheral neuropathies: Strategies for the development, application, and repair of regenerative biomaterials	30
Neurodevelopmental defects as a primer of neurodegeneration: lessons from spinal muscular atrophy and Huntington's disease	30
Blocking postsynaptic density-93 binding to C-X3-C motif chemokine ligand 1 promotes microglial phenotypic transformation during acute ischemic stroke	29
Status of precision medicine approaches to traumatic brain injury	29
microRNA-455-5p alleviates neuroinflammation in cerebral ischemia/reperfusion injury	29
Role of calcium homeostasis in retinal ganglion cell degeneration	29
NOVA1 promotes SMN2 exon 7 splicing by binding the UCAC motif and increases SMN protein expression	29
A core scientific problem in the treatment of central nervous system diseases: newborn neurons	29
Ruxolitinib attenuates secondary injury after traumatic spinal cord injury	29
The secondary injury cascade after spinal cord injury: an analysis of local cytokine/chemokine regulation	29
Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson’s disease	29
Functions and mechanisms of cytosolic phospholipase A2 in central nervous system trauma	29
Exacerbation of neuronal senescence after spinal cord injury: Role of the macrophage-derived transforming growth factor-β1-SMAD2 signaling axis	29
Amyloid degradation mechanisms and potential synergistic effects	29
Regulatory role of neuronal guidance proteins in spinal cord injury	29
Homer signaling pathways as effective therapeutic targets for ischemic and traumatic brain injuries and retinal lesions	28
NLRP3/1-mediated pyroptosis: beneficial clues for the development of novel therapies for Alzheimer’s disease	28
Dysfunction of synaptic endocytic trafficking in Parkinson’s disease	28
Neuroprotection provided by polyphenols and flavonoids in photoreceptor degenerative diseases	28
A Drosophila perspective on retina functions and dysfunctions	28
Erythropoietin inhibits ferroptosis and ameliorates neurological function after spinal cord injury	28
Utilizing engineered extracellular vesicles as delivery vectors in the management of ischemic stroke: a special outlook on mitochondrial delivery	28
Biochanin A attenuates spinal cord injury in rats during early stages by inhibiting oxidative stress and inflammasome activation	28
A review of the neurotransmitter system associated with cognitive function of the cerebellum in Parkinson’s disease	27
Microglia depletion as a therapeutic strategy: friend or foe in multiple sclerosis models?	27
M2 macrophages mediate fibrotic scar formation in the early stages after cerebral ischemia in rats	27
Semaphorin7A: its role in the control of serotonergic circuits and functional recovery following spinal cord injury	27
Post-acute ischemic stroke hyperglycemia aggravates destruction of the blood-brain barrier	27
Effects of electroacupuncture on the functionality of NG2-expressing cells in perilesional brain tissue of mice following ischemic stroke	27
Small extracellular vesicles derived from cerebral endothelial cells with elevated microRNA 27a promote ischemic stroke recovery	27
Pharmacological interventions targeting the microcirculation following traumatic spinal cord injury	27
Letter from the Editor-in-Chief	27
Neuron-fibrous scaffold interfaces in the peripheral nervous system: a perspective on the structural requirements	27
Treatment with β-sitosterol ameliorates the effects of cerebral ischemia/reperfusion injury by suppressing cholesterol overload, endoplasmic reticulum stress, and apoptosis	27
Interferon regulatory factor 1 enhances T cell differentiation in patients with myasthenia gravis	27
The neuroprotective effects of oxygen therapy in Alzheimer’s disease: a narrative review	27
Implication of gut microbiome in age-related macular degeneration	26
Schwann cells differentiated from skin-derived precursors provide neuroprotection via autophagy inhibition in a cellular model of Parkinson’s disease	26

Heterogeneity of mature oligodendrocytes in the central nervous system	26
Profile of the RNA in exosomes from astrocytes and microglia using deep sequencing: implications for neurodegeneration mechanisms	26
Post-transcriptional mechanisms controlling neurogenesis and direct neuronal reprogramming	26
Multiple sclerosis drug repurposing for neuroregeneration	26
Role of microtubule dynamics in Wallerian degeneration and nerve regeneration after peripheral nerve injury	26
Magnesium-L-threonate treats Alzheimer’s disease by modulating the microbiota-gut-brain axis	26
Artificial nerve graft constructed by coculture of activated Schwann cells and human hair keratin for repair of peripheral nerve defects	26
Knockout of Sirt2 alleviates traumatic brain injury in mice	26
Anti-vascular endothelial growth factor drugs combined with laser photocoagulation maintain retinal ganglion cell integrity in patients with diabetic macular edema: study protocol for a prospective, n	25
The critical role of the endolysosomal system in cerebral ischemia	25
Delayed activation of leg somatotopic fibers of an injured corticospinal tract in a patient with cerebral infarction	25
Interconnections between diabetic corneal neuropathy and diabetic retinopathy: diagnostic and therapeutic implications	25
Biomaterial-based strategies: a new era in spinal cord injury treatment	25
Neuronal autosis: the self-destructive side of autophagy involved in hypoxic-ischemic neuronal death	25
Diabetic corneal neuropathy as a surrogate marker for diabetic peripheral neuropathy	25
Genetic and pathway complexity in Alzheimer’s disease: Insights from multi-omic data about the immune response and mitochondrial function	25
Neuronal chemokines: new insights into neuronal communication after injury	25
The “mitochondrial stress responses”: the “Dr. Jekyll and Mr. Hyde” of neuronal disorders	25
Contribution of glial cells to the neuroprotective effects triggered by repetitive magnetic stimulation	25
Schwann cell extracellular vesicles: judging a book by its cover	25
Metformin remodels the myelin landscape	25
Imaging mass spectrometry: a molecular microscope for studying the role of lipids in Parkinson’s disease	25
Boosting proteolytic pathways as a treatment against glycation-derived damage in the brain?	25
Stiffness-tunable biomaterials provide a good extracellular matrix environment for axon growth and regeneration	25
Facial reanimation with interposition nerve graft or masseter nerve transfer: a comparative retrospective study	24
Data and subject heterogeneity and data sharing: keys to translational success in spinal cord injury research?	24
Application value of biofluid-based biomarkers for the diagnosis and treatment of spinal cord injury	24
Complement activation kindles the transition of acute post-traumatic brain injury to a chronic inflammatory disease	24
Mechanosensitive Piezo1 channel regulation of microglial cell function and implications to neurodegenerative diseases and neuroinflammation	24
Bioactive material promotes long-distance regeneration of optic nerve to restore visual functions	24
Carboplatin restores neuronal toxicity in FUS-linked amyotrophic lateral sclerosis	24
Tau’s function and dysfunction in the brain	24
Clues from a missense mutation of the adenosine A1 receptor gene associated with early-onset Parkinson’s disease	24
Two become one: combination of two risk factors in a new glaucoma animal model	24
Graphene oxide-composited chitosan scaffold contributes to functional recovery of injured spinal cord in rats	24
Making bridges between preclinical and clinical insights into age-related cognitive decline	24
Current progress of mitochondrial therapy for neural regeneration	24
5-Hydroxytryptamine: a potential therapeutic target in amyotrophic lateral sclerosis	24
Time-to-enrollment in clinical trials investigating neurological recovery in chronic spinal cord injury: observations from a systematic review and ClinicalTrials.gov database	23
Brain-derived cell-free DNA	23
Differential distribution of PINK1 and Parkin in the primate brain implies distinct roles	23
Emerging roles of astrocytes in blood-brain barrier disruption upon amyloid-beta insults in Alzheimer's disease	23
Adipose mesenchymal stem cell-derived extracellular vesicles reduce glutamate-induced excitotoxicity in the retina	23
Transcranial electrical stimulation in neurological disease	23
Insights into the transcriptomic heterogeneity of brain endothelial cells in normal aging and Alzheimer’s disease	23
Blood-brain barrier pathology in cerebral small vessel disease	23
Transcranial photobiomodulation for the brain: a wide range of clinical applications	23
Fasudil-modified macrophages reduce inflammation and regulate the immune response in experimental autoimmune encephalomyelitis	23
Matrin-3 dysfunction in myopathy and motor neuron degeneration	23
Low-intensity transcranial ultrasound neuromodulation promotes neuronal regeneration: A new hope for noninvasive treatment of neurodegenerative diseases	23
Oxidative stress in retinal pigment epithelium degeneration: from pathogenesis to therapeutic targets in dry age-related macular degeneration	23
Effects of delayed repair of peripheral nerve injury on the spatial distribution of motor endplates in target muscle	23
Microglial depletion impairs glial scar formation and aggravates inflammation partly by inhibiting STAT3 phosphorylation in astrocytes after spinal cord injury	22
Brain-penetrating neurotrophic factor mimetics: HER-096 as a disease-modifying therapy for Parkinson’s disease	22
Striatum-specific mechanisms regulate neuronal cell cycle re-entry: the choice between life and death	22
Neuron-neuron attraction shapes morphology and activity of tissue engineered brain constructs	22
Exploring the synergy of the eye-brain connection: neuromodulation approaches for neurodegenerative disorders through transcorneal electrical stimulation	22
Sex differences in Alzheimer’s disease: an urgent research venue to follow	22
Secretase inhibition in Alzheimer’s disease therapeutics reveals functional roles of amyloid-beta42	22
Neural and Müller glial adaptation of the retina to photoreceptor degeneration	22
Cerebral dopamine neurotrophic factor transfection in dopamine neurons using neurotensin-polyplex nanoparticles reverses 6-hydroxydopamine-induced nigrostriatal neurodegeneration	22
Synaptic pathology in multiple sclerosis: a role for Nogo-A signaling in astrocytes?	22
Gut microbiota neurotransmitters: influence on risk and outcome of ischemic stroke	22
Actin(g) toward a revised understanding of the role of cytoskeletal dynamics in neuronal bioenergetics	22
Can foods influence the onset and progress of neurodegenerative diseases?	22
Effects of quercetin and its derivatives in in vivo models of neuroinflammation: A systematic review and meta-analysis	22
The effects and potential of microglial polarization and crosstalk with other cells of the central nervous system in the treatment of Alzheimer’s disease	22
Stable isotope labeling-mass spectrometry as a new approach to determine remyelination	22
Optogenetic neuroregeneration	22
Retraction: Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotection	22
Brain and spinal cord trauma: what we know about the therapeutic potential of insulin growth factor 1 gene therapy	22
Strategies to treat neurodegeneration in neuronal ceroid lipofuscinosis: a view onto the retina	22
How physical and motor training affect cognitive performance: lessons from an inflammatory molecule	21
Magnetic resonance imaging focused on the ferritin heavy chain 1 reporter gene detects neuronal differentiation in stem cells	21
Rebuilding insight into the pathophysiology of Alzheimer's disease through new blood-brain barrier models	21
Multifaceted superoxide dismutase 1 expression in amyotrophic lateral sclerosis patients: a rare occurrence?	21
MicroRNA and Alzheimer's disease: Diagnostic biomarkers and potential therapeutic targets	21
Molecular mechanisms after optic nerve injury: Neurorepair strategies from a transcriptomic perspective	21
Krüppel-like factor 7 attenuates hippocampal neuronal injury after traumatic brain injury	21
Secretory autophagy in neurons: More than throwing out the trash?	21
A novel approach in preventing vascular leakage and angiogenesis in wet age-related macular degeneration	21
Fibrinogen’s potential role in connecting cerebrovascular abnormalities with glymphatic dysfunction in Alzheimer’s disease	21
Exosomes in stroke management: A promising paradigm shift in stroke therapy	21
Unexpected role of complement component 8 gamma chain in the inflamed brain	21
Brain organoids and genome editing: A new era in understanding human brain development and disorders	21
Proteostasis decline and endoplasmic reticulum stress in aging: Implications for cellular senescence and senescence-associated secretory phenotype regulation	21
Inhibitory gamma-aminobutyric acidergic neurons in the anterior cingulate cortex participate in the comorbidity of pain and emotion	21
Alpha-synuclein-induced upregulation of SKI family transcriptional corepressor 1: A new player in aging and Parkinson’s disease?	21
Deuterated dextromethorphan/quinidine for agitation in Alzheimer’s disease	21
Activity-dependent remodeling of genome architecture in engram cells facilitates memory formation and recall	21
Gut microbiota dysbiosis contributes to α-synuclein-related pathology associated with C/EBPβ/AEP signaling activation in a mouse model of Parkinson's disease	21
Rethinking microglia from a circadian perspective in neuroimmunology: New insights	21
Persistent alterations in gray matter in COVID-19 patients experiencing sleep disturbances: a 3-month longitudinal study	21
Remaking a connection: molecular players involved in post-injury synapse formation	21
cGAS–STING pathway modulation: A new hope for neural regeneration	21